V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20005544 | 20085281 | 1.87 | 63.6 | Palliative (P) | 2016-10-24 | 2016-11-21 | SCALOP-2 Trial | 01 | N | SCALOP-2 TRIAL | 101189936 |
| 20005628 | 20085282 | 1.73 | 96.7 | null | 2020-05-11 | 2020-05-11 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101677285 |
| 20005706 | 20085283 | 1.53 | 54.5 | null | 2017-03-10 | 2017-03-10 | Enzalutamide | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100726210 |
| 20005812 | 20085285 | 1.57 | 68 | Palliative (P) | 2018-02-03 | 2018-03-13 | Enzalutamide | 99 | N | TRASTUZUMAB | 100520357 |
| 20005828 | 20085286 | 1.96 | 74 | Neo-adjuvant (N) | 2020-02-29 | 2020-02-29 | Enzalutamide | N | N | OXALIPLATIN + RALTITREXED | 101736660 |
| 20005852 | 20085289 | 1.87 | 76 | Curative (C) | 2018-10-26 | 2018-10-27 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100517317 |
| 20006216 | 20085291 | 1.75 | 78.5 | Curative (C) | null | 2018-06-07 | Mitomycin Intravesical | 02 | Y | MITOMYCIN INTRAVESICULAR | 100195483 |
| 20006331 | 20085292 | 1.75 | 81 | Neo-adjuvant (N) | 2019-03-17 | 2019-04-08 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100047188 |
| 20006348 | 20085293 | 1.87 | 91.6 | Palliative (P) | 2017-11-30 | 2018-01-05 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101784764 |
| 20006374 | 20085294 | 1.85 | 67.3 | Palliative (P) | 2017-06-05 | 2017-06-09 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100683070 |
| 20006418 | 20085295 | 1.73 | 68.3 | Curative (C) | 2021-05-12 | 2021-06-02 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100667447 |
| 20006496 | 20085296 | 1.67 | 90 | Neo-adjuvant (N) | 2018-08-18 | 2018-08-20 | Enzalutamide | null | N | ECF | 100584517 |
| 20006580 | 20085297 | 1.66 | 71.4 | Palliative (P) | 2017-10-29 | 2017-11-01 | Carboplatin AUC 2 - 5 | 02 | N | OXALIPLATIN + RALTITREXED | 101222096 |
| 20006609 | 20085298 | null | 45.2 | Curative (C) | 2019-05-18 | 2019-05-18 | Enzalutamide | 02 | Y | LUTETIUM-177 | 101155104 |
| 20006671 | 20085299 | 1.9 | 79 | Palliative (P) | null | 2018-05-14 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101545979 |
| 20006755 | 20085300 | 1.6 | 90 | Palliative (P) | 2019-07-02 | 2019-07-13 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101793626 |
| 20006810 | 20085302 | 1.63 | 96.7 | Adjuvant (A) | 2020-01-19 | 2020-01-31 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100080268 |
| 20006967 | 20085303 | 1.6 | 67.3 | null | 2018-06-22 | 2018-06-22 | Enzalutamide | 02 | null | CETUXIMAB + OXALIPLATIN + MDG | 100429372 |
| 20007033 | 20085304 | 1.72 | 97 | 03 | 2017-09-17 | 2017-09-30 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101846804 |
| 20007151 | 20085305 | null | 73.9 | Curative (C) | 2017-11-30 | 2017-12-19 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101433284 |
| 20007182 | 20085307 | 1.67 | 68.3 | Palliative (P) | 2018-09-13 | 2018-09-30 | Enzalutamide | 02 | N | OCTREOTIDE | 100547832 |
| 20007191 | 20085308 | 1.59 | 51 | Palliative (P) | 2018-04-19 | 2018-04-21 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100706275 |
| 20007196 | 20085309 | 1.7 | 65.9 | Curative (C) | 2019-06-23 | 2019-06-26 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101059287 |
| 20007227 | 20085311 | 1.68 | 46.3 | 03 | 2019-01-24 | 2019-02-04 | CARBOPLATIN + PACLITAXEL + RT | 02 | Y | CETUXIMAB + OXALIPLATIN + MDG | 100791162 |
| 20007278 | 20085312 | 1.62 | 56.9 | Palliative (P) | 2017-10-28 | 2017-10-28 | Enzalutamide | 02 | N | CISPLATIN | 100701057 |
| 20007339 | 20085313 | null | null | null | 2017-07-16 | 2017-07-16 | Enzalutamide | 99 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100782631 |
| 20007416 | 20085314 | 1.57 | 65 | null | 2017-02-18 | 2017-03-09 | Capecitabine + Cisplatin + RT | 02 | null | CAPECITABINE + CISPLATIN + RT | 101774181 |
| 20007453 | 20085315 | 1.62 | 182.5 | Neo-adjuvant (N) | 2018-01-15 | 2018-01-16 | Capecitabine + Cisplatin + RT | 02 | N | SCALOP-2 TRIAL | 100567298 |
| 20007469 | 20085316 | 1.69 | 91.3 | Palliative (P) | 2021-06-27 | 2021-07-09 | Enzalutamide | 02 | N | TRASTUZUMAB | 100543302 |
| 20007480 | 20085317 | 1.63 | 105.7 | Palliative (P) | 2020-02-05 | 2020-02-07 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 101136480 |
| 20007527 | 20085318 | 1.62 | 112.9 | Palliative (P) | 2019-07-13 | 2019-07-31 | Enzalutamide | 02 | N | ECF | 101206055 |
| 20007628 | 20085319 | 1.78 | 81.1 | 03 | 2019-11-08 | 2019-11-23 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100417881 |
| 20007852 | 20085321 | 1.7 | 80.6 | Palliative (P) | null | 2016-07-18 | Enzalutamide | 02 | N | OCTREOTIDE | 101162059 |
| 20007859 | 20085322 | 1.53 | 76.4 | Palliative (P) | 2016-07-14 | 2016-07-22 | Enzalutamide | null | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101240520 |
| 20007934 | 20085323 | 1.58 | 91.25 | Neo-adjuvant (N) | 2016-12-26 | 2016-12-26 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100324232 |
| 20007996 | 20085326 | 1.76 | 75.6 | Palliative (P) | 2018-11-28 | 2018-12-05 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 100360429 |
| 20008032 | 20085327 | 1.82 | null | Palliative (P) | 2019-02-16 | 2019-03-10 | Enzalutamide | 02 | N | CETUXIMAB | 100891073 |
| 20008087 | 20085328 | 1.78 | 77 | Adjuvant (A) | 2017-06-08 | 2017-06-17 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101376266 |
| 20008138 | 20085329 | 1.9 | 67.7 | Palliative (P) | 2019-08-10 | 2019-08-11 | Enzalutamide | 02 | N | ECF | 100660534 |
| 20008172 | 20085331 | 1.7 | 80.95 | Palliative (P) | 2017-10-12 | 2017-10-30 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101480989 |
| 20008210 | 20085332 | 1.62 | null | Curative (C) | null | 2018-04-11 | Enzalutamide | 2 | N | ECF | 101547209 |
| 20008484 | 20085335 | 1.6 | null | Palliative (P) | 2018-11-30 | 2018-12-03 | Enzalutamide | null | N | ECF | 101217504 |
| 20008583 | 20085336 | 1.6 | null | Adjuvant (A) | 2016-07-29 | 2016-07-31 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 100368805 |
| 20008590 | 20085337 | 1.66 | 49.7 | null | 2018-07-31 | 2018-07-31 | Enzalutamide | 02 | null | OCTREOTIDE | 100132386 |
| 20008596 | 20085338 | null | 59 | Palliative (P) | 2020-01-27 | 2020-01-27 | Enzalutamide | 02 | null | SCALOP-2 TRIAL | 101201095 |
| 20008679 | 20085339 | 1.8 | 63.9 | Curative (C) | 2019-06-30 | 2019-06-30 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100065775 |
| 20008694 | 20085340 | 1.58 | 45 | Palliative (P) | 2019-12-22 | 2019-12-23 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101547470 |
| 20008724 | 20085341 | 1.67 | 72.3 | Palliative (P) | null | 2018-01-20 | Enzalutamide | 99 | N | CAPECITABINE + CISPLATIN + RT | 100302022 |
| 20008835 | 20085342 | 1.54 | 48.3 | Neo-adjuvant (N) | 2020-02-16 | 2020-02-16 | Enzalutamide | 02 | Y | CETUXIMAB | 101396006 |
| 20009011 | 20085343 | 1.59 | 78.8 | null | 2019-02-26 | 2019-03-04 | Enzalutamide | N | null | CETUXIMAB + OXALIPLATIN + MDG | 100527232 |